COMP <GO>
SNWV vs SRTS // RETURN ON INVESTED CAPITAL (ROIC)
SANUWAVE Health Inc. (NASDAQ) VS. Sensus Healthcare Inc. (NASDAQ) • 15-METRIC TALLY: SNWV 8
— SRTS 1
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: SNWV
LAST: $5.15 (-2.28%) • MKT CAP: $45.3M
roic
67.30%
LAST: $2.76 (-0.36%) • MKT CAP: $45.6M
roic
-31.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. SRTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNWV | SRTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.10% | 43.20% | +33.90 | SNWV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 67.30% | -31.30% | +98.60 | SNWV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 0.73% | +3.54 | SNWV | /fcf-yield <GO> |
| Operating Margin | 11.20% | -37.50% | +48.70 | SNWV | /operating-margins <GO> |
| Net Profit Margin | 26.80% | -28.10% | +54.90 | SNWV | /net-margins <GO> |
| Revenue Growth (YoY) | 36.30% | -34.30% | +70.60 | SNWV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 6.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | SNWV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 40.3 | +12.80 | SNWV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.3M | $45.6M | -$265.7K | SRTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNWV REV | SRTS REV | SNWV GROSS % | SRTS GROSS % | SNWV FCF | SRTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.1M | $27.5M | 77.1% | 43.2% | $1.9M | $332.0K |
| FY 2024 | $32.3M | $41.8M | 75.9% | 58.4% | $2.0M | -$1.1M |
| FY 2023 | $19.3M | $24.4M | — | — | -$4.5M | -$2.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
SRTS // BETA —